Literature DB >> 2293467

Methamphetamine. Stimulant of the 1990s?

R W Derlet1, B Heischober.   

Abstract

During the past several years, the use of a smokable form of methamphetamine hydrochloride called "ice" has increased rapidly. The heaviest use has occurred on the West Coast and in Hawaii. Many regional emergency departments treat more methamphetamine users than cocaine-intoxicated patients. The ease of synthesis from inexpensive and readily available chemicals makes possible the rampant abuse of a dangerous drug that can produce a euphoria similar to that induced by cocaine. Clinicians should be familiar with the medical effects and treatment of acute methamphetamine toxicity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2293467      PMCID: PMC1002639     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  31 in total

1.  Update on amphetamine abuse.

Authors:  B Heischober; R W Derlet
Journal:  West J Med       Date:  1989-07

2.  Effects of transplacental exposure to cocaine and methamphetamine on the neonate.

Authors:  S D Dixon
Journal:  West J Med       Date:  1989-04

3.  Long-term effects of chronic methamphetamine administration in rhesus monkeys.

Authors:  W L Woolverton; G A Ricaurte; L S Forno; L S Seiden
Journal:  Brain Res       Date:  1989-05-01       Impact factor: 3.252

4.  Diazepam in the prevention of seizures and death in cocaine-intoxicated rats.

Authors:  R W Derlet; T E Albertson
Journal:  Ann Emerg Med       Date:  1989-05       Impact factor: 5.721

5.  Behavioural and biochemical comparison of amphetamine derivatives, cocaine, benztropine and tricyclic anti-depressant drugs.

Authors:  J Scheel-Krüger
Journal:  Eur J Pharmacol       Date:  1972-04       Impact factor: 4.432

Review 6.  Cocaine and other stimulants. Actions, abuse, and treatment.

Authors:  F H Gawin; E H Ellinwood
Journal:  N Engl J Med       Date:  1988-05-05       Impact factor: 91.245

7.  Intracerebral haemorrhage and vasculitis secondary to amphetamine use.

Authors:  V Salanova; R Taubner
Journal:  Postgrad Med J       Date:  1984-06       Impact factor: 2.401

8.  'Eve' and 'Ecstasy'. A report of five deaths associated with the use of MDEA and MDMA.

Authors:  G P Dowling; E T McDonough; R O Bost
Journal:  JAMA       Date:  1987-03-27       Impact factor: 56.272

Review 9.  'Designer drugs'. A problem in clinical toxicology.

Authors:  J F Buchanan; C R Brown
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Jan-Dec

10.  Protection against d-amphetamine toxicity.

Authors:  R W Derlet; T E Albertson; P Rice
Journal:  Am J Emerg Med       Date:  1990-03       Impact factor: 2.469

View more
  22 in total

1.  The dopamine D3 receptor partial agonist CJB090 and antagonist PG01037 decrease progressive ratio responding for methamphetamine in rats with extended-access.

Authors:  Laura Orio; Sunmee Wee; Amy H Newman; Luigi Pulvirenti; George F Koob
Journal:  Addict Biol       Date:  2010-04-29       Impact factor: 4.280

2.  Biphasic effects of selegiline on striatal dopamine: lack of effect on methamphetamine-induced dopamine depletion.

Authors:  K Grasing; R Azevedo; S Karuppan; S Ghosh
Journal:  Neurochem Res       Date:  2001-01       Impact factor: 3.996

3.  Characteristics of Asian and Pacific Islanders admitted to U.S. drug treatment programs in 2005.

Authors:  Wynnie Wong; Paul G Barnett
Journal:  Public Health Rep       Date:  2010 Mar-Apr       Impact factor: 2.792

Review 4.  The need for speed: an update on methamphetamine addiction.

Authors:  Alasdair M Barr; William J Panenka; G William MacEwan; Allen E Thornton; Donna J Lang; William G Honer; Tania Lecomte
Journal:  J Psychiatry Neurosci       Date:  2006-09       Impact factor: 6.186

5.  (+/-)-3,4-Methylenedioxymethamphetamine treatment in adult rats impairs path integration learning: a comparison of single vs once per week treatment for 5 weeks.

Authors:  Matthew R Skelton; Jessica A Able; Curtis E Grace; Nicole R Herring; Tori L Schaefer; Gary A Gudelsky; Charles V Vorhees; Michael T Williams
Journal:  Neuropharmacology       Date:  2008-07-12       Impact factor: 5.250

6.  Sex differences in (+)-amphetamine- and (+)-methamphetamine-induced behavioral response in male and female Sprague-Dawley rats.

Authors:  Alessandra Milesi-Hallé; Donald E McMillan; Elizabeth M Laurenzana; Kelly A Byrnes-Blake; S Michael Owens
Journal:  Pharmacol Biochem Behav       Date:  2007-01-09       Impact factor: 3.533

Review 7.  Respiratory toxicities from stimulant use.

Authors:  T E Albertson; W F Walby
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

Review 8.  Neurologic manifestations of chronic methamphetamine abuse.

Authors:  Daniel E Rusyniak
Journal:  Neurol Clin       Date:  2011-06-24       Impact factor: 3.806

9.  Alterations in body temperature, corticosterone, and behavior following the administration of 5-methoxy-diisopropyltryptamine ('foxy') to adult rats: a new drug of abuse.

Authors:  Michael T Williams; Nicole R Herring; Tori L Schaefer; Matthew R Skelton; Nicholas G Campbell; Jack W Lipton; Anne E McCrea; Charles V Vorhees
Journal:  Neuropsychopharmacology       Date:  2006-10-18       Impact factor: 7.853

10.  Behavioral and growth effects induced by low dose methamphetamine administration during the neonatal period in rats.

Authors:  Michael T Williams; Mary S Moran; Charles V Vorhees
Journal:  Int J Dev Neurosci       Date:  2004 Aug-Oct       Impact factor: 2.457

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.